Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 62.46 CNY -6.09% Market Closed
Market Cap: 12B CNY
Have any thoughts about
Shanghai Haohai Biological Technology Co Ltd?
Write Note

Relative Value

The Relative Value of one Shanghai Haohai Biological Technology Co Ltd stock under the Base Case scenario is 110.39 CNY. Compared to the current market price of 62.46 CNY, Shanghai Haohai Biological Technology Co Ltd is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
110.39 CNY
Undervaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
66
Median 3Y
7.9
Median 5Y
9.3
Industry
7.7
Forward
4.1
vs History
90
vs Industry
6
Median 3Y
58.2
Median 5Y
61.7
Industry
22.7
Forward
29.6
vs History
90
vs Industry
9
Median 3Y
45.5
Median 5Y
53.6
Industry
21.6
vs History
65
vs Industry
7
Median 3Y
64.4
Median 5Y
66.6
Industry
25.2
vs History
90
vs Industry
42
Median 3Y
3.3
Median 5Y
3.5
Industry
2.5
vs History
90
vs Industry
61
Median 3Y
6.6
Median 5Y
8.2
Industry
7.7
Forward
3.3
vs History
90
vs Industry
54
Median 3Y
9.6
Median 5Y
11.1
Industry
9
vs History
90
vs Industry
6
Median 3Y
60.8
Median 5Y
69.5
Industry
4.2
Forward
13
vs History
90
vs Industry
6
Median 3Y
60.8
Median 5Y
69.5
Industry
4.1
Forward
15.9
vs History
90
vs Industry
10
Median 3Y
38.1
Median 5Y
44.8
Industry
5.7
vs History
71
vs Industry
4
Median 3Y
150.4
Median 5Y
190.2
Industry
3.6
vs History
90
vs Industry
46
Median 3Y
3.8
Median 5Y
4.3
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Shanghai Haohai Biological Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
12B CNY 4.4 27 20.5 20.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.6 -76.2
P/E Multiple
Earnings Growth
CN
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Average P/E: 178.1
27
37%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Average EV/EBITDA: 17.7
20.5
122%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.6 N/A
EV/EBIT Multiple
EBIT Growth
CN
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Average EV/EBIT: 22.2
20.5
112%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top